Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1973-8-16
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0012-3714
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
34
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
167-71
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:4711885-Aged,
pubmed-meshheading:4711885-Carbidopa,
pubmed-meshheading:4711885-Dihydroxyphenylalanine,
pubmed-meshheading:4711885-Drug Synergism,
pubmed-meshheading:4711885-Evaluation Studies as Topic,
pubmed-meshheading:4711885-Female,
pubmed-meshheading:4711885-Humans,
pubmed-meshheading:4711885-Hydrazines,
pubmed-meshheading:4711885-Male,
pubmed-meshheading:4711885-Middle Aged,
pubmed-meshheading:4711885-Parkinson Disease
|
| pubmed:articleTitle |
MK 486 and levodopa in treatment of Parkinsonism.
|
| pubmed:publicationType |
Journal Article
|